New updates have been reported about Artera.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Artera is using HIMSS26 to underscore its position in agentic AI for patient communications, anchoring its strategy around real-world deployments of AI agents that automate scheduling, intake, refills, triage, and other access workflows. The company will run expert-led sessions at booth #6421, demonstrating how its AI agents, built to combine human and machine intelligence, are delivering measurable gains in patient experience and staff efficiency for more than 1,000 healthcare provider organizations.
The showcase follows two key milestones for Artera: recognition as the 2026 Best in KLAS winner for Patient Communications, with straight A- scores across all six KLAS categories, and surpassing $100 million in contracted annual recurring revenue (CARR). Management is positioning these achievements as validation of its product-market fit and long-term role as a strategic partner for providers seeking scalable, AI-driven patient access solutions.
At HIMSS26, Artera will center its programming on agentic AI education and adoption frameworks, reflecting customer demand for credible, operationally grounded AI. A fireside chat with Signify Research will present new analysis on Voice AI in specialty practices, focusing on how call volume pressure and staffing instability make patient access a critical lever for revenue capture and operational resilience, with an “ROI Credibility Ladder” framework to evaluate financial defensibility of AI investments.
Additional sessions will address Model Context Protocol (MCP) as a potential interoperability layer to reduce AI hallucinations and security risk, a topic central to making agentic AI safe for patient-facing automation. Artera executives will outline how MCP and robust security frameworks fit into the company’s architecture, which is designed to operate in highly regulated environments and is progressing through FedRAMP High while already maintaining SOC 2 Type 2, HITRUST certification, and HIPAA compliance.
The company will also offer masterclasses on evaluating, deploying, and scaling autonomous AI agents in patient communication and access, along with one-on-one “office hours” for provider executives to map AI capabilities to their specific operational bottlenecks. These engagements are aimed at accelerating adoption of Artera’s Virtual Agent portfolio, which includes AI Agents, Flows Agents, and Co-Pilots that customers have already used to save millions of staff hours since their launch in 2024.
Artera’s leadership is framing its strategy around augmenting, not replacing, human staff, emphasizing that its products are designed as staff-augmentation tools rather than substitutes for clinical judgment or institutional oversight. The company stresses that performance outcomes depend on each provider’s configuration and data environment, but it sees growing adoption, strong KLAS feedback, and expanding use cases as indicators that agentic AI will become a structural component of patient access infrastructure.
For healthcare organizations, Artera’s trajectory signals a maturing vendor with meaningful scale—2 billion annual communications across 200 million patients and more than a decade of operational experience—combined with a deepening focus on security, interoperability, and measurable ROI. As payers and providers push to reduce administrative burden and protect margins, Artera is positioning its agentic AI stack as a way to unlock capacity, improve patient engagement, and strengthen the financial performance of ambulatory, specialty, and large integrated delivery networks alike.